| Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas M Kool, A Korshunov, M Remke, DTW Jones, M Schlanstein, PA Northcott, ... Acta neuropathologica 123, 473-484, 2012 | 1152 | 2012 |
| Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition M Kool, DTW Jones, N Jäger, PA Northcott, TJ Pugh, V Hovestadt, ... Cancer cell 25 (3), 393-405, 2014 | 826 | 2014 |
| Germline mutations of the paired–like homeobox 2B (PHOX2B) gene in neuroblastoma D Trochet, F Bourdeaut, I Janoueix-Lerosey, A Deville, L De Pontual, ... The American Journal of Human Genetics 74 (4), 761-764, 2004 | 429 | 2004 |
| Cytogenetic prognostication within medulloblastoma subgroups DJH Shih, PA Northcott, M Remke, A Korshunov, V Ramaswamy, M Kool, ... Journal of clinical oncology 32 (9), 886-896, 2014 | 364 | 2014 |
| SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas F Le Loarer, S Watson, G Pierron, VT de Montpreville, S Ballet, N Firmin, ... Nature genetics 47 (10), 1200-1205, 2015 | 318 | 2015 |
| SWI/SNF chromatin remodeling and human malignancies J Masliah-Planchon, I Bièche, JM Guinebretière, F Bourdeaut, O Delattre Annual Review of Pathology: Mechanisms of Disease 10 (1), 145-171, 2015 | 317 | 2015 |
| Atypical teratoid/rhabdoid tumors—current concepts, advances in biology, and potential future therapies MC Frühwald, JA Biegel, F Bourdeaut, CWM Roberts, SN Chi Neuro-oncology 18 (6), 764-778, 2016 | 234 | 2016 |
| Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor F Bourdeaut, D Lequin, L Brugieres, S Reynaud, C Dufour, F Doz, ... Clinical Cancer Research 17 (1), 31-38, 2011 | 234 | 2011 |
| Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors J Theruvath, E Sotillo, CW Mount, CM Graef, A Delaidelli, S Heitzeneder, ... Nature medicine 26 (5), 712-719, 2020 | 225 | 2020 |
| Retinoblastoma and neuroblastoma predisposition and surveillance J Kamihara, F Bourdeaut, WD Foulkes, JJ Molenaar, YP Mossé, ... Clinical Cancer Research 23 (13), e98-e106, 2017 | 217 | 2017 |
| Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium “Care for CMMR-D”(C4CMMR-D) HFA Vasen, Z Ghorbanoghli, F Bourdeaut, O Cabaret, O Caron, A Duval, ... Journal of medical genetics 51 (5), 283-293, 2014 | 210 | 2014 |
| Accumulation of segmental alterations determines progression in neuroblastoma G Schleiermacher, I Janoueix-Lerosey, A Ribeiro, J Klijanienko, ... Journal of Clinical Oncology 28 (19), 3122-3130, 2010 | 201 | 2010 |
| TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma M Remke, V Ramaswamy, J Peacock, DJH Shih, C Koelsche, ... Acta neuropathologica 126, 917-929, 2013 | 198 | 2013 |
| Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus B Ho, PD Johann, Y Grabovska, MJ De Dieu Andrianteranagna, F Yao, ... Neuro-oncology 22 (5), 613-624, 2020 | 186 | 2020 |
| Cancer surveillance in Gorlin syndrome and rhabdoid tumor predisposition syndrome WD Foulkes, J Kamihara, DGR Evans, L Brugières, F Bourdeaut, ... Clinical Cancer Research 23 (12), e62-e67, 2017 | 185 | 2017 |
| Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study C Dufour, A Beaugrand, MC Le Deley, F Bourdeaut, N André, P Leblond, ... Cancer 118 (15), 3812-3821, 2012 | 183 | 2012 |
| Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing P Euskirchen, F Bielle, K Labreche, WP Kloosterman, S Rosenberg, ... Acta neuropathologica 134, 691-703, 2017 | 181 | 2017 |
| A phase I study of the CDK4/6 inhibitor ribociclib (LEE011) in pediatric patients with malignant rhabdoid tumors, neuroblastoma, and other solid tumors B Geoerger, F Bourdeaut, SG DuBois, M Fischer, JI Geller, NG Gottardo, ... Clinical Cancer Research 23 (10), 2433-2441, 2017 | 178 | 2017 |
| Aberrant ERBB4-SRC signaling as a hallmark of group 4 medulloblastoma revealed by integrative phosphoproteomic profiling A Forget, L Martignetti, S Puget, L Calzone, S Brabetz, D Picard, ... Cancer cell 34 (3), 379-395. e7, 2018 | 145 | 2018 |
| Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group NG Gottardo, JR Hansford, JP McGlade, F Alvaro, DM Ashley, S Bailey, ... Acta neuropathologica 127, 189-201, 2014 | 143 | 2014 |
